These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 14632666)

  • 1. Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.
    Winkler B; Bolwig C; Seppälä U; Spangfort MD; Ebner C; Wiedermann U
    Immunology; 2003 Nov; 110(3):376-85. PubMed ID: 14632666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
    Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
    Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy.
    Müller U; Schmid-Grendelmeier P; Hausmann O; Helbling A
    Allergy; 2012 Aug; 67(8):1069-73. PubMed ID: 22676144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C
    J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.
    Neis MM; Merk HF
    Cutan Ocul Toxicol; 2012 Jun; 31(2):117-23. PubMed ID: 21995714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Component-resolved diagnosis of wasp (yellow jacket) venom allergy.
    Ebo DG; Faber M; Sabato V; Leysen J; Bridts CH; De Clerck LS
    Clin Exp Allergy; 2013 Feb; 43(2):255-61. PubMed ID: 23331567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.
    Müller UR; Johansen N; Petersen AB; Fromberg-Nielsen J; Haeberli G
    Allergy; 2009 Apr; 64(4):543-8. PubMed ID: 19120073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The culprit insect but not severity of allergic reactions to bee and wasp venom can be determined by molecular diagnosis.
    Gattinger P; Lupinek C; Kalogiros L; Silar M; Zidarn M; Korosec P; Koessler C; Novak N; Valenta R; Mittermann I
    PLoS One; 2018; 13(6):e0199250. PubMed ID: 29940036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.
    Blank S; Seismann H; Bockisch B; Braren I; Cifuentes L; McIntyre M; Rühl D; Ring J; Bredehorst R; Ollert MW; Grunwald T; Spillner E
    J Immunol; 2010 May; 184(9):5403-13. PubMed ID: 20348419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy.
    Mittermann I; Zidarn M; Silar M; Markovic-Housley Z; Aberer W; Korosec P; Kosnik M; Valenta R
    J Allergy Clin Immunol; 2010 Jun; 125(6):1300-1307.e3. PubMed ID: 20466415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved sensitivity to venom specific-immunoglobulin E by spiking with the allergen component in Japanese patients suspected of Hymenoptera venom allergy.
    Yoshida N; Hirata H; Watanabe M; Sugiyama K; Arima M; Fukushima Y; Ishii Y
    Allergol Int; 2015 Jul; 64(3):248-52. PubMed ID: 26117256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitellogenins are new high molecular weight components and allergens (Api m 12 and Ves v 6) of Apis mellifera and Vespula vulgaris venom.
    Blank S; Seismann H; McIntyre M; Ollert M; Wolf S; Bantleon FI; Spillner E
    PLoS One; 2013; 8(4):e62009. PubMed ID: 23626765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Component-resolved diagnosis in selecting patients for yellowjacket venom immunotherapy.
    Kukkonen AK; Pelkonen AS; Edelman SM; Kauppi PM; Mäkelä MJ
    Ann Allergy Asthma Immunol; 2018 Feb; 120(2):184-189. PubMed ID: 29413342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies.
    Caruso B; Bonadonna P; Bovo C; Melloni N; Lombardo C; Senna G; Lippi G
    Clin Chim Acta; 2016 Jan; 453():170-3. PubMed ID: 26719033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
    Binder M; Fierlbeck G; King Ti; Valent P; Bühring HJ
    Int Arch Allergy Immunol; 2002 Oct; 129(2):160-8. PubMed ID: 12403934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
    Int Immunol; 1999 Oct; 11(10):1717-24. PubMed ID: 10508191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy.
    Möbs C; Müller J; Rudzio A; Pickert J; Blank S; Jakob T; Spillner E; Pfützner W
    Allergy; 2015 Jun; 70(6):715-9. PubMed ID: 25753563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Component-resolved diagnosis in vespid venom-allergic individuals.
    Galindo-Bonilla PA; Galán-Nieto A; Alfaya-Arias T; García-Rodríguez C; de la Roca-Pinzón F; Feo-Brito F
    Allergol Immunopathol (Madr); 2015; 43(4):398-402. PubMed ID: 25192862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
    Ewan PW; Deighton J; Wilson AB; Lachmann PJ
    Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.